DOI:
10.1055/s-00000136
Endo-Praxis
LinksClose Window
References
Hoffmann M, Kleine-Weber H, Schroeder S. et al.
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically
Proven Protease Inhibitor.
Cell, 16. April 2020;
181: 271-280.e8
We do not assume any responsibility for the contents of the web pages of other providers.